| 26/08/2022 |
EU funding: Selenium Containing Rupturing Dendritic Prodrugs for Therapeutic Applications |
| 01/06/2022 |
EU funding (€1,499,932): Tracing virus-specific CD8+ T cell clonotype zonation and function in humans |
| 12/11/2022 |
EU funding (€1,499,993): Mechanisms of Social Learning in Social Contagion and Cultural Evolution |
| 29/12/2022 |
EU funding (€1,500,000): Rewiring gene regulatory circuits to enhance central nervous system repair |
| 25/07/2022 |
EU funding (€1,500,000): Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorder |
| 26/07/2022 |
EU funding (€1,999,981): Dissecting a stepwise principle of cellular diversification to instruct regeneration in the enteric nervous system |
| 16/12/2022 |
EU funding (€10.9M): Building REsilience against MEntal illness during ENDocrine-sensitive life stages |
| 01/06/2022 |
EU funding (€120,000): Single molecule reconstruction for high-throughput, short-read sequencing technologies |
| 01/06/2022 |
EU funding (€2,489,571): Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platform |
| 28/07/2022 |
EU funding (€2,500,000): Descending control of pain |
| 16/09/2022 |
EU funding (€2,557,901): Quality Control of the Mitochondrial Gene Expression System in Health and Disease |
| 04/09/2022 |
EU funding (€2,747,621): Learning from animals how to regenerate: multidisciplinary training programme in regenerative biology |
| 26/08/2022 |
EU funding (€2,812,437): A PeRsOnalized Prevention roadmap for the future HEalThcare |
| 01/05/2022 |
EU funding (€200M): Partnership for the Assessment of Risks from Chemicals |
| 09/11/2022 |
EU funding (€206,888): Binding the self: how cortical oscillations bind sensory stimuli into a multisensory representation of the physical self |
| 04/08/2022 |
EU funding (€206,888): Innervation-driven mechanisms of bile duct development |
| 01/06/2022 |
EU funding (€206,888): Perception in Action: Neural Dynamics of Sensorimotor Interactions in Touch |
| 01/09/2022 |
EU funding (€22.6M): BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL |
| 04/09/2022 |
EU funding (€222,728): Identification of Transiently Formed Immune-Endogenous Neural Stem Cell Niches in Spinal Cord Injury |
| 28/07/2022 |
EU funding (€222,728): Mechanisms of cell plasticity in the liver |
| 28/07/2022 |
EU funding (€222,728): Nanoscale analysis of symmetry and molecular membrane topography |
| 05/08/2022 |
EU funding (€222,728): Targeted delivery of lipid nanoparticle-mRNA formulations modified with ligand pattern to dendritic cells based on DNA origami |
| 01/06/2022 |
EU funding (€3,739,724): NEUROendocrine SENSor for Sudden Unexpected Death in Epilepsy (SUDEP) prediction and prevention |
| 01/07/2022 |
EU funding (€30,000): Highly multiplexed, quantitative protein biomarker profiling (hmqPro) |
| 04/08/2022 |
EU funding (€34,481): In cellular conformations of microRNA-34a via magnetic resonance |
| 01/08/2022 |
EU funding (€4,252,852): Deliberative improvement of oral care quality |
| 02/08/2022 |
EU funding (€4,674,996): OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE |
| 04/09/2022 |
EU funding (€4,836,125): Research Analysis Identifier SystEm |
| 28/07/2022 |
EU funding (€5,838,576): International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning |
| 01/09/2022 |
EU funding (€5,857,774): A holistic approach in patient management and epidemic surveillance through convergence of diagnostic technologies, capacity building and stakeholder engagement |
| 16/09/2022 |
EU funding (€5,925,463): PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors |
| 01/09/2022 |
EU funding (€6,476,658): Skills for the European Open Science Commons: Creating a Training Ecosystem for Open and FAIR Science |
| 01/06/2022 |
EU funding (€6,718,139): The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine |
| 28/07/2022 |
EU funding (€6,754,010): Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D |
| 26/08/2022 |
EU funding (€6,932,308): Epigenetic regulation of host factors in viral infections (EPIVINF) |
| 18/11/2022 |
EU funding (€6,993,396): CArdiovascularREsolution of INflammation to promote HEALTH |
| 28/11/2022 |
EU funding (€6,997,523): More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making |
| 29/11/2022 |
EU funding (€7,451,044): Inflammation in human early life: targeting impacts on life-course health |
| 28/07/2022 |
EU funding (€7,597,250): Respiratory Host-Pathogen Interaction |
| 01/09/2022 |
EU funding (€7,814,549): A European-wide foundation to accelerate Data-driven Cancer Research |
| 02/08/2022 |
EU funding (€7,830,787): Identification of chemical and biological determinants, their sources, and strategies to promote healthier homes in Europe |
| 01/09/2022 |
EU funding (€8,456,504): Risk and Resilience in Developmental Diversity and Mental Health |
| 01/12/2022 |
EU funding (€8,689,222): Early Interception of Inflammatory-mediated Type 2 Diabetes |
| 29/11/2022 |
EU funding (€9,197,603): Maximising Impact of Prescription Drugs in Rheumatoid Arthritis |
| 26/08/2022 |
EU funding (€9,255,879): Heat Indicators for Global Health (HIGH Horizons): monitoring, Early Warning Systems and health facility interventions for pregnant and postpartum women, infants and young children and health workers |
| 30/12/2022 |
EU funding (€9,838,840): PANcreatic CAncer Initial Detection via liquid biopsy |
